On Tuesday, Agios Pharmaceuticals Inc (NASDAQ: AGIO) was 7.30% up from the session before settling in for the closing price of $26.49. A 52-week range for AGIO has been $22.24 – $62.45.
When this article was written, the company’s average yearly earnings per share was at -160.46%. With a float of $54.94 million, this company’s outstanding shares have now reached $58.28 million.
Agios Pharmaceuticals Inc (AGIO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Agios Pharmaceuticals Inc stocks. The insider ownership of Agios Pharmaceuticals Inc is 5.79%, while institutional ownership is 108.35%. The most recent insider transaction that took place on Nov 12 ’25, was worth 8,768. In this transaction Director of this company sold 200 shares at a rate of $43.84, taking the stock ownership to the 17,603 shares. Before that another transaction happened on Nov 11 ’25, when Company’s Chief Medical Officer sold 2,454 for $43.78, making the entire transaction worth $107,436. This insider now owns 61,727 shares in total.
Agios Pharmaceuticals Inc (AGIO) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -1.74 earnings per share (EPS) during the time that was less than consensus figure (set at -1.63) by -0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.93 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -160.46% per share during the next fiscal year.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
You can see what Agios Pharmaceuticals Inc (AGIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 13.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 37.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.96, a number that is poised to hit -1.95 in the next quarter and is forecasted to reach -6.66 in one year’s time.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
Agios Pharmaceuticals Inc (NASDAQ: AGIO) saw its 5-day average volume 7.11 million, a positive change from its year-to-date volume of 0.84 million. As of the previous 9 days, the stock’s Stochastic %D was 18.85%.
During the past 100 days, Agios Pharmaceuticals Inc’s (AGIO) raw stochastic average was set at 26.03%, which indicates a significant increase from 26.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.19 in the past 14 days, which was higher than the 1.78 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.54, while its 200-day Moving Average is $34.97. Nevertheless, the first resistance level for the watch stands at $29.25 in the near term. At $30.07, the stock is likely to face the second major resistance level. The third major resistance level sits at $31.52. If the price goes on to break the first support level at $26.98, it is likely to go to the next support level at $25.54. The third support level lies at $24.71 if the price breaches the second support level.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Key Stats
There are 58,314K outstanding shares of the company, which has a market capitalization of 1.66 billion. As of now, sales total 36,500 K while income totals 673,730 K. Its latest quarter income was 12,880 K while its last quarter net income were -103,430 K.
